1. Home
  2. PMT vs AGMB Comparison

PMT vs AGMB Comparison

Compare PMT & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

N/A

Current Price

$9.68

Market Cap

812.7M

Sector

Real Estate

ML Signal

N/A

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$15.94

Market Cap

652.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMT
AGMB
Founded
2009
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
652.5M
IPO Year
2009
2024

Fundamental Metrics

Financial Performance
Metric
PMT
AGMB
Price
$9.68
$15.94
Analyst Decision
Hold
Buy
Analyst Count
5
3
Target Price
$13.50
$32.00
AVG Volume (30 Days)
1.1M
143.2K
Earning Date
05-05-2026
04-23-2026
Dividend Yield
13.33%
N/A
EPS Growth
N/A
N/A
EPS
0.40
N/A
Revenue
$351,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.55
$17.86
P/E Ratio
$24.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.05
$8.75
52 Week High
$13.80
$17.82

Technical Indicators

Market Signals
Indicator
PMT
AGMB
Relative Strength Index (RSI) 54.80 65.59
Support Level $9.11 $9.54
Resistance Level $9.83 $17.31
Average True Range (ATR) 0.17 0.97
MACD 0.06 0.12
Stochastic Oscillator 86.24 97.53

Price Performance

Historical Comparison
PMT
AGMB

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: